1-Benzyl-4-methyl-2,3-piperazindion | 918428-84-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-Benzyl-4-methyl-2,3-piperazindion
• 英文别名: 1-benzyl-4-methylpiperazine-2,3-dione；2,3-Piperazinedione, 1-methyl-4-(phenylmethyl)-
• CAS: 918428-84-9
• 化学式: C₁₂H₁₄N₂O₂
• 分子量: 218.255
• InChiKey: BTNIVGROSQQBGW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  40.6
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  4-苄基-1-甲基哌嗪 在 碘苯二乙酸 、 碘 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 1.5h， 以65%的产率得到1-Benzyl-4-methyl-2,3-piperazindion
  参考文献：
  名称：

  PIDA/I₂-Mediated α- and β-C(sp³)–H Bond Dual Functionalization of Tertiary Amines

  摘要：

  The alpha,beta-C(sp(3))-H bond dual functionalization of tertiary amines is still a challenging task for both organic and medicinal chemists. Herein a direct, mild, metal-free, and site-specific method mediated by PIDA/I-2 was developed for alpha,beta-C(sp(3))-H bond dual functionalization of tertiary amines, and this method can provide facile access to alpha-keto lactams or rarely studied alpha,alpha-diiodo lactams. Moreover, this method was used for the effective syntheses of three natural products [obscurumine C (13), obscurumine O (17), and strychnocarpine (18)] and direct preparation of mimics of the in vivo metabolites of two FDA-approved drugs (imatinib and donepezil) in 36-60% overall yield. The method represents a promising protocol for the late-stage alpha,beta-C(sp(3))-H bond oxidative dual functionalization of tertiary amine-containing drugs and complex natural products.

  DOI：

  10.1021/acs.joc.8b01424

文献信息

• Compositions useful as inhibitors of voltage-gated sodium channels
  申请人：Gonzalez E. Jesus

  公开号：US20060025415A1

  公开（公告）日：2006-02-02

  The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及用作电压门控钠通道抑制剂的化合物。本发明还提供了包含本发明化合物的药学上可接受的组合物以及使用这些组合物治疗各种疾病的方法。
• Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels
  申请人：Gonzalez, III Jesus E.

  公开号：US20100087479A1

  公开（公告）日：2010-04-08

  The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及一种作为电压门控钠离子通道抑制剂有用的化合物。本发明还提供了包含本发明化合物的药学上可接受的组合物，并提供了使用这些组合物治疗各种疾病的方法。
• COMPOSITIONS USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS
  申请人：Gonzalez, III Jesus E.

  公开号：US20120238578A1

  公开（公告）日：2012-09-20

  The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及用作电压门控钠通道抑制剂的化合物。本发明还提供了包括本发明化合物的药学上可接受的组合物以及使用这些组合物治疗各种疾病的方法。
• Moehrle; Azodi, Pharmazie, 2006, vol. 61, # 10, p. 815 - 822
  作者：Moehrle、Azodi

  DOI：——

  日期：——
• US7615563B2
  申请人：——

  公开号：US7615563B2

  公开（公告）日：2009-11-10